Could a cell infusion free organ transplant patients from lifelong drugs?

NCT ID NCT06997471

Recruiting now Disease control Sponsor: Francisco Hernández Oliveros Source: ClinicalTrials.gov ↗

First seen May 13, 2026 · Last updated Jun 18, 2026 · Updated 4 times

Summary

This early-stage trial tests whether giving a special mix of blood cells after an organ transplant can help the body accept the new organ without needing lifelong anti-rejection drugs. About 10 children and adults receiving kidney, lung, or intestinal transplants will get the cell infusion after a short preparation. The main goal is to see if the approach is safe and can reduce rejection and infections.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID ORGAN TRANSPLANT COMPLICATIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

La Paz University Hospital
RECRUITING

Madrid, Madrid, 28046, Spain

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

disease related to solid organ transplantation transplant rejection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID ORGAN TRANSPLANT COMPLICATIONS SOLID ORGAN TRANSPLANT COMPLICATIONS SOLID ORGAN TRANSPLANT RECIPIENTS SOLID ORGAN TRANSPLANT REJECTION